{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:36:28Z","timestamp":1777440988071,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T00:00:00Z","timestamp":1354233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00415-012-6770-5","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T16:35:19Z","timestamp":1354206919000},"page":"1116-1121","source":"Crossref","is-referenced-by-count":28,"title":["Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene"],"prefix":"10.1007","volume":"260","author":[{"given":"Francesco","family":"Sacc\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Puorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Antenora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Scoppettuolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Nesti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Brescia Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"De Michele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo M.","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Filla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,30]]},"reference":[{"key":"6770_CR1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","volume":"104","author":"AE Harding","year":"1981","unstructured":"Harding AE (1981) Friedreich\u2019s ataxia: a clinical and genetic stud of 90 families with analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104:589\u2013620","journal-title":"Brain"},{"key":"6770_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/ars.2009.3015","volume":"13","author":"R Santos","year":"2010","unstructured":"Santos R, Lefevre S, Sliwa D et al (2010) Friedreich Ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid Redox Signal 13:651\u2013690","journal-title":"Antioxid Redox Signal"},{"key":"6770_CR3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molt\u00f2 MD et al (1996) Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423\u20131427","journal-title":"Science"},{"key":"6770_CR4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nsmb.1579","volume":"16","author":"S Adinolfi","year":"2009","unstructured":"Adinolfi S, Iannuzzi C, Prischi F et al (2009) Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat Struct Mol Biol 16:390\u2013396","journal-title":"Nat Struct Mol Biol"},{"key":"6770_CR5","doi-asserted-by":"crossref","unstructured":"Anheim M, Mariani LL, Calvas P et al (2012) Exonic deletions of FXN and early-onset Friedreich ataxia. Arch Neurol 69:912\u2013916","DOI":"10.1001\/archneurol.2011.834"},{"key":"6770_CR6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.54.2.496","volume":"54","author":"G Michele De","year":"2000","unstructured":"De Michele G, Filla A, Cavalcanti F et al (2000) Atypical Friedreich ataxia phenotype associated with a novel missense mutation in the X25 gene. Neurology 54:496\u2013499","journal-title":"Neurology"},{"key":"6770_CR7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U","volume":"45","author":"M Coss\u00e9e","year":"1999","unstructured":"Coss\u00e9e M, D\u00fcrr A, Schmitt M et al (1999) Friedreich\u2019s ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol 45:200\u2013206","journal-title":"Ann Neurol"},{"key":"6770_CR8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.68.5.661","volume":"68","author":"ML McCormack","year":"2000","unstructured":"McCormack ML, Guttmann RP, Schumann M et al (2000) Frataxin point mutations in two patients with Friedreich\u2019s ataxia and unusual clinical features. J Neurol Neurosurg Psychiatry 68:661\u2013664","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6770_CR9","doi-asserted-by":"crossref","first-page":"e17627","DOI":"10.1371\/journal.pone.0017627","volume":"6","author":"F Sacc\u00e0","year":"2011","unstructured":"Sacc\u00e0 F, Puorro G, Antenora A et al (2011) A combined nucleic acid and protein analysis in Friedreich ataxia: implication for diagnosis, pathogenesis and clinical trial design. PLoSOne 6:e17627","journal-title":"PLoSOne"},{"key":"6770_CR10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L et al (2006) Scale for the assessment and rating of ataxia: development os a new clinical scale. Neurology 66:1717\u20131720","journal-title":"Neurology"},{"key":"6770_CR11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.23435","volume":"26","author":"F Sacc\u00e0","year":"2011","unstructured":"Sacc\u00e0 F, Piro R, De Michele G et al (2011) Epoetin alfa increases Frataxin production in Friedreich\u2019s Ataxia without affecting hematocrit. Mov Disord 26:739\u2013742","journal-title":"Mov Disord"},{"key":"6770_CR12","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"MW Pfaffl","year":"2002","unstructured":"Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36","journal-title":"Nucleic Acids Res"},{"key":"6770_CR13","first-page":"S54","volume":"S9","author":"A Filla","year":"1996","unstructured":"Filla A, De Michele G, Cavalcanti F et al (1996) The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich Ataxia. Am J Hum Genet S9:S54\u2013S60","journal-title":"Am J Hum Genet"},{"key":"6770_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mds.23879","volume":"27","author":"C Marelli","year":"2012","unstructured":"Marelli C, Figoni J, Charles P et al (2012) Annual change in Friedreich\u2019s ataxia evaluated by the Scale for the Assessment and Rating of Ataxia (SARA) is independent of disease severity. Mov Disord 27:135\u2013138","journal-title":"Mov Disord"},{"key":"6770_CR15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ymgme.2010.07.001","volume":"101","author":"EC Deutsch","year":"2010","unstructured":"Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA et al (2010) A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab 101:238\u2013245","journal-title":"Mol Genet Metab"},{"key":"6770_CR16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0969-2126(00)00158-1","volume":"8","author":"G Musco","year":"2000","unstructured":"Musco G, Stier G, Kolmerer B et al (2000) Towards a structural understanding of Friedreich\u2019s ataxia: the solution structure of frataxin. Structure\u00a08:695\u2013707","journal-title":"Structure"},{"key":"6770_CR17","doi-asserted-by":"crossref","first-page":"30753","DOI":"10.1074\/jbc.C000407200","volume":"275","author":"S Dhe-Paganon","year":"2000","unstructured":"Dhe-Paganon S, Shigeta R, Chi YI, Ristow M, Shoelson SE (2000) Crystal structure of human frataxin. J Biol Chem 275:30753\u201330756","journal-title":"J Biol Chem"},{"key":"6770_CR18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0168-8278(01)00037-X","volume":"34","author":"CL Hammond","year":"2001","unstructured":"Hammond CL, Lee TK, Ballatori N (2001) Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 34:946\u2013954","journal-title":"J Hepatol"},{"key":"6770_CR19","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/11.24.3055","volume":"11","author":"ML Jauslin","year":"2002","unstructured":"Jauslin ML, Wirth T, Meier T, Schoumacher F (2002) A cellular model of Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet 11:3055\u20133063","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6770-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6770-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:23:10Z","timestamp":1559071390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-012-6770-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,30]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["6770"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6770-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,30]]}}}